These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18362025)

  • 21. Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease.
    Tomaske M; Bauersfeld U
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S35-7. PubMed ID: 18226033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calculating stationary electrical fields in detailed models of the human heart using finite element analysis].
    Müller M; Meyer-Waarden K
    Biomed Tech (Berl); 1997; 42 Suppl():199-200. PubMed ID: 9517112
    [No Abstract]   [Full Text] [Related]  

  • 23. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 24. Modeling for Electromagnetic Characterization, Prediction, and Reconstruction.
    Sadleir R
    Adv Exp Med Biol; 2022; 1380():17-45. PubMed ID: 36306093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter-defibrillator insertion in congenital heart disease without transvenous access to the heart.
    Nery PB; Green MS; Khairy P; Alhebaishi Y; Hendry P; Birnie DH
    Can J Cardiol; 2013 Feb; 29(2):254.e1-3. PubMed ID: 22749646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of implantable cardioverter-defibrillators (ICD) in children and adolescents].
    Apitz C; Gass M; Dörnberger V; Kuehlkamp V; Hofbeck M
    Klin Padiatr; 2006; 218(5):270-5. PubMed ID: 16947095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations in S-ICD therapy: reasons for system explantation.
    Frommeyer G; Dechering DG; Zumhagen S; Köbe J; Eckardt L; Reinke F
    Clin Res Cardiol; 2015 Oct; 104(10):902-7. PubMed ID: 26150113
    [No Abstract]   [Full Text] [Related]  

  • 28. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
    Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
    Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease.
    Walsh EP
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S38-40. PubMed ID: 18226034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips.
    Khairy P; Mansour F
    Heart Rhythm; 2011 Mar; 8(3):480-3. PubMed ID: 21056119
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping.
    Zeb M; Curzen N; Veldtman G; Yue A; Roberts P; Wilson D; Morgan J
    Europace; 2015 Jul; 17(7):1059-67. PubMed ID: 25678600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Optimizing 2-electrode arrays of implantable defibrillators].
    Wurtz S; Müller M; Meyer-Waarden K
    Biomed Tech (Berl); 1998; 43 Suppl():374-5. PubMed ID: 9859405
    [No Abstract]   [Full Text] [Related]  

  • 33. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool.
    Zeb M; Curzen N; Allavatam V; Wilson D; Yue A; Roberts P; Morgan J
    Int J Cardiol; 2015 Sep; 195():205-9. PubMed ID: 26048376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atrial fibrillation and flutter in children and young adults with congenital cardiopathies].
    Gow RM
    Can J Cardiol; 1996 Feb; 12 Suppl A():43A-48A. PubMed ID: 8673952
    [No Abstract]   [Full Text] [Related]  

  • 36. Implantable defibrillators: from the adult cardiac to the grown up congenital heart disease patient.
    Gatzoulis K; Frogoudaki A; Brili S; Stefanadis C
    Int J Cardiol; 2004 Dec; 97 Suppl 1():117-22. PubMed ID: 15590088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter defibrillators in electric and magnetic fields of 400 kV power lines.
    Korpinen L; Kuisti H; Elovaara J; Virtanen V
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):297-303. PubMed ID: 24033389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A right-sided subcutaneous implantable cardioverter defibrillator in a patient with congenital heart disease.
    Waller JR; Salmon AP; Roberts PR
    Europace; 2015 Jan; 17(1):77. PubMed ID: 25414482
    [No Abstract]   [Full Text] [Related]  

  • 39. Membrane polarization induced in the myocardium by defibrillation fields: an idealized 3-D finite element bidomain/monodomain torso model.
    Huang Q; Eason JC; Claydon FJ
    IEEE Trans Biomed Eng; 1999 Jan; 46(1):26-34. PubMed ID: 9919823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ICDs in adults with congenital heart disease: an overview.
    Ferns SJ; Naccarelli G
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1591-3. PubMed ID: 24215188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.